Author: Chen, Wei; Zhang, Jie; Qin, Xijian; Wang, Weixiao; Xu, Miaomiao; Wang, Lin-Fa; Xu, Chuanjun; Tang, Shuangshuang; Liu, Pei; Zhang, Libo; Liu, Xuan; Zhang, Yongchen; Yi, Changhua; Hu, Zhiliang; Yi, Yongxiang
Title: SARS-CoV-2 neutralizing antibody levels are correlated with severity of COVID-19 pneumonia Cord-id: cirq6pfx Document date: 2020_8_13
ID: cirq6pfx
Snippet: Abstract The emerging coronavirus disease 2019 (COVID-19) has become a serious global public health threat. With more and more recovered patients, it is urgently needed for evaluation of the neutralizing antibody (NAb) in these patients. In this study, we collected blood samples from 49 patients recently recovered from COVID-19. Serum NAbs were measured using a novel surrogate virus neutralization test (sVNT). Factors associated with NAb titers were analyzed using Ordinary Least Squares regressi
Document: Abstract The emerging coronavirus disease 2019 (COVID-19) has become a serious global public health threat. With more and more recovered patients, it is urgently needed for evaluation of the neutralizing antibody (NAb) in these patients. In this study, we collected blood samples from 49 patients recently recovered from COVID-19. Serum NAbs were measured using a novel surrogate virus neutralization test (sVNT). Factors associated with NAb titers were analyzed using Ordinary Least Squares regression model. The median age of the study participants was 37 years (IQR, 30.0-54.5) and 55.1% (27/49) of which were male. The median time to blood collection (for NAb analysis) from illness onset, viral clearance and discharge were 43.0 days (IQR, 36.0-50.0), 27.0 days (IQR, 20.5-37) and 17.0 days (IQR, 15.0-33.0), respectively. Patients had a median NAb titer of 1: 40 (IQR, 1:15-1:120). NAbs were not detected in two asymptomatic children who quickly cleared the virus. NAb titers were higher in patients with older age (p = 0.020), symptomatic infection (p = 0.044), more profound lung involvement (p<0.001), abnormal C-reactive protein level (p<0.01) and elevated lactate dehydrogenase (p = 0.019). Multivariable analysis revealed that severity of pneumonia and having comorbidity positively correlated with NAb titers in recovered patients (p = 0.02), while use of corticosteroids negatively impacted NAb titers (p = 0.01). Our study suggests that some COVID-19 patients may not have detectable NAb after recovery. SARS-CoV-2 NAb titers are positively correlated with severity of COVID-19 pneumonia.
Search related documents:
Co phrase search for related documents- absolute value and lung injury: 1, 2
- accurate measurement and lung injury: 1
- ade antibody dependent enhancement and lung injury: 1
- admission time and lung damage: 1, 2, 3, 4
- admission time and lung injury: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10
- admission time and lung injury severity: 1
- live virus and lung damage: 1, 2, 3, 4, 5, 6
- live virus and lung epithelial cell: 1, 2
- live virus and lung injury: 1
- lobar score and lung damage: 1
- local centers and lung injury: 1, 2
- lopinavir ritonavir and low lymphocyte count high crp level: 1
- lopinavir ritonavir and lung damage: 1, 2, 3, 4, 5, 6
- lopinavir ritonavir and lung injury: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12
- low lymphocyte count and lung injury: 1
Co phrase search for related documents, hyperlinks ordered by date